Actiogen Acne Dots Treatment
FDA Label NDC 69186-001

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Actiogen Corp for the product Actiogen Acne Dots Treatment (NDC 69186-001). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredients, purpose, use, warnings, when using this product, stop using this product, do not use, consult a physician, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

Active Ingredients

Salicylic Acid 2%

Purpose

Acne Treatment

Use

For the treatment of acne

Warnings

For external use only

When Using This Product

Using other topical acne medication at the same time or immediately following use of this product may increase dryness or irritation of the skin.  If this occurs, only one medication should be used unless directed by a doctor

Stop Using This Product

Discontinue use if you notice an redness, burning, or other forms of irritation

Do Not Use

Do not use on broken skin or open wounds

Consult A Physician

Consult your physician in case of adverse reaction

Keep Out Of Reach Of Children

Keep away from children

Other Information

Store in a cool dry place.

Inactive Ingredients

Acrylic adhesive, kollidon, 1,2 Propylene Glycol, Zinc Oxide

Package Label.Principal Display Panel

Front of Box

* Please review the disclaimer below.